Kitano Y - Search Results

1

Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment.

Kobayashi K, Ono Y, Kitano Y, Oba A, Sato T, Ito H, Mise Y, Shinozaki E, Inoue Y, Yamaguchi K, Saiura A, Takahashi Y. Kobayashi K, et al. Among authors: kitano y. Ann Surg Oncol. 2023 Nov;30(12):7338-7347. doi: 10.1245/s10434-023-13781-0. Epub 2023 Jun 26. Ann Surg Oncol. 2023. PMID: 37365416

2

Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients.

Kitano Y, Yamashita YI, Nakao Y, Itoyama R, Yusa T, Umezaki N, Tsukamoto M, Yamao T, Miyata T, Nakagawa S, Okabe H, Imai K, Chikamoto A, Ishiko T, Baba H. Kitano Y, et al. Ann Surg Oncol. 2020 Feb;27(2):599-607. doi: 10.1245/s10434-019-07701-4. Epub 2019 Aug 12. Ann Surg Oncol. 2020. PMID: 31407173

3

Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function?

Imai K, Yamashita YI, Nakao Y, Matsumoto T, Kinoshita S, Yusa T, Kitano Y, Kaida T, Hayashi H, Baba H. Imai K, et al. Among authors: kitano y. Ann Surg Oncol. 2021 Feb;28(2):854-862. doi: 10.1245/s10434-020-08960-2. Epub 2020 Aug 1. Ann Surg Oncol. 2021. PMID: 32740735

4

Optimizing the selection of technically unresectable colorectal liver metastases.

Kobayashi K, Inoue Y, Kitano Y, Sato S, Oba A, Ono Y, Sato T, Ito H, Mise Y, Saiura A, Takahashi Y. Kobayashi K, et al. Among authors: kitano y. Surgery. 2023 Feb;173(2):442-449. doi: 10.1016/j.surg.2022.10.013. Epub 2022 Nov 13. Surgery. 2023. PMID: 36384649

5

Survival impact of pancreatic resection for metastases in the pancreas: A retrospective multi-center study.

Kinoshita S, Yamashita YI, Kitano Y, Hayashi H, Sugimachi K, Nishizaki T, Fukuzawa K, Kajiyama K, Miyanari N, Yoshizumi T, Takamori H, Baba H. Kinoshita S, et al. Among authors: kitano y. Surg Oncol. 2023 Jun;48:101942. doi: 10.1016/j.suronc.2023.101942. Epub 2023 Mar 31. Surg Oncol. 2023. PMID: 37043926

6

Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery.

Kitano Y, Inoue Y, Takeda T, Oba A, Ono Y, Sato T, Ito H, Ozaka M, Sasaki T, Sasahira N, Baba H, Takahashi Y. Kitano Y, et al. Ann Surg Oncol. 2023 Aug;30(8):5093-5102. doi: 10.1245/s10434-023-13534-z. Epub 2023 May 4. Ann Surg Oncol. 2023. PMID: 37140750

7

[No title available]

[No authors listed] [No authors listed] PMID: 37173612

8

[No title available]

[No authors listed] [No authors listed] PMID: 37598123

9

Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study.

Kitano Y, Ono Y, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Shinozaki E, Yamaguchi K, Saiura A, Baba H, Takahashi Y. Kitano Y, et al. HPB (Oxford). 2024 Feb;26(2):282-290. doi: 10.1016/j.hpb.2023.10.015. Epub 2023 Oct 28. HPB (Oxford). 2024. PMID: 37985325

10

Laparoscopic Portal Vein Ligation and Embolization During First-Stage Hepatectomy for Initially Unresectable Colorectal Liver Metastases.

Ono Y, Inoue Y, Kobayashi K, Sato S, Kitano Y, Oba A, Sato T, Ito H, Takahashi Y. Ono Y, et al. Among authors: kitano y. Ann Surg Oncol. 2024 May;31(5):3069-3070. doi: 10.1245/s10434-024-14955-0. Epub 2024 Jan 30. Ann Surg Oncol. 2024. PMID: 38291303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

611 results

Search Page

Filters